A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19
Critical Care
; 26(1):1-3, 2022.
Article
in English
| BioMed Central | ID: covidwho-1958476
Search on Google
Collection:
Databases of international organizations
Database:
BioMed Central
Type of study:
Experimental Studies
/
Randomized controlled trials
Language:
English
Journal:
Critical Care
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS